Pelthos Therapeutics Inc.

PTHS · Biological Products, (No Disgnostic Substances)

Save to watchlist Sign in to save

Latest available SEC filing: 4 ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • PTHS · 171126204 - Common Stock, par value $0.0001 per share
Company details and SEC sources

CIK 0001919246 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
PTHS on NYSE
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
Business address
4020 Stirrup Creek Drive, Suite 110, Durham, NC, 27703
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
NV
Fiscal year end
31 December
Former names on EDGAR
Channel Therapeutics Corp (to 27 May 2025), Chromocell Therapeutics Corp (to 15 Nov 2024)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .